Levels of serum inflammatory biomarkers—such as C-reactive protein—fluctuate substantially over time in patients undergoing dialysis. Monitoring these changes could provide us with useful information concerning the underlying processes that cause inflammation. In this Review, Meuwese and colleagues examine the implications and causes of inflammatory marker variability in patients on dialysis, and discuss the advantages of repeated measurements of inflammation over single measurements in clinical practice.
- Christiaan L. Meuwese
- Peter Stenvinkel
- Juan J. Carrero
